Hem › Medulloblastom › New Jersey
Kliniska studier för Medulloblastom i New Jersey
3 studier för Medulloblastom söker deltagare vid platser i New Jersey.
Officiell studietext (engelska)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Saint Peter's University Hospital, New Brunswick
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick
- Newark Beth Israel Medical Center, Newark
- och 1 fler
RekryterarFas 3
Ålder 4 till 21 · Alla kön · Uppdaterad 25 aug. 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Hackensack University Medical Center, Hackensack
RekryterarFas 2
Upp till ålder 21 · Alla kön · Uppdaterad 12 aug. 2026 · NCT04696029A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RekryterarFas 1
Ålder 3 till 22 · Alla kön · Uppdaterad 13 juli 2026 · NCT07698899Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.